Tagungen und Workshops zum Thema Legislation in der Medizin und Pharmakologie

Wählen Sie ein Land aus
ALLE LÄNDER (10)
1
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
23. Sep 2019 - 25. Sep 2019 • Washington, D.C., Vereinigte Staaten
Veranstalter:
American Statistical Association
Eintrags-ID:
1145536
2
Biosimilars — SMi's 10th Annual Biosimilars Conference
25. Sep 2019 - 26. Sep 2019 • London, Großbritannien
Kontakt:
Tel.: [02078276000];     Email: ssapal@smi-online.co.uk
Themen:
Biosimilar, Biobetters, biologic, generic drug, immunogenicity, innovator, interchangeability, pharmacist, doctors, dosage, legislation, commercialising biosimilars, patent protection
Eintrags-ID:
1219429
3
Pharmacovigilance — 19th Pharmacovigilance 2019
08. Okt 2019 - 10. Okt 2019 • Boston, Vereinigte Staaten
Zusammenfassung:
will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
Kontakt:
Tel.: [+44 2036120886];     Email: kavitha@virtueinsight.co.in
Themen:
Pharmacovigilance, DrugSafety, ProductSafety, DrugDevelopment, ClinicalSafety, patientsafety, RiskManagement, regulatoryaffairs
Eintrags-ID:
1247539
4
MEDLAWCONGRESS — 3rd INTERNATIONAL MEDICAL LAW CONGRESS
09. Okt 2019 - 12. Okt 2019 • Antalya, Türkei
Zusammenfassung:
We invite physicians, judges, prosecutors, lawyers, academic members and lecturers, other healthcare professionals and teaching assistants and students in the relevant field to present papers and to participate in our congress. In addition to the main and secondary topics of the congress, presentations can be made on any topic or subject which may have contribution in terms of both practice and theory. During the Congress, there will also be questions and answers sessions and courses running alongside the main programme.
Kontakt:
Tel.: [+9005305050666];     Email: ygdogramaci@yahoo.com
Themen:
MAIN TOPIC: CONSENT FOR MEDICAL TREATMENT o Consent for Medical Treatment of a Minor Child o Consent for Medical Treatment of an Adult o Possible Exceptions to Consent Requirement for Medical Treatment o Ethical Dilemmas concerning Possible Exceptions to Consent Requirement for Medical Treatment o Presumed Consent o Extension of an Operation o Medical Will o Refusal of Resuscitation under Turkish Law o Problems of Proof and Evidence • THE PRACTICE OF BIOTECHNOLOGY AND LAW o Designer Baby o Assessment of Artificial Intelligence with respect to Medical Law o Stem Cell Research o Human Cloning • ORGAN AND TISSUE TRANSPLANTATION o Amendments with the Law No. 7151 o Harmonisation Activities with the European Union Legislation • ARTIFICIAL INSEMINATION o Human Embryo within Medical Law and Legal Problems o Surrogate Motherhood in light of the Recent Amendments o Consequences of the Amendments with the Law No. 7151 on Artificial Insemination • PRIVACY AND PROTECTION OF PERSONAL DATA o Assessment of E-health Application from the Perspective of Patient Privacy and Personal Data o The Process and Decision of the Personal Data Protection Committee in the field of Medical Law o Problems with Reporting the Pregnancies under the Age of 18 • THE RIGHTS OF HEALTHCARE PROFESSIONALS o Right to Protection against Violence • THE LAW OF MEDICINE AND MEDICAL DEVICES • THE LAW OF HEALTH TOURISM • PALLIATIVE CARE AND MEDICAL LAW CHALLENGES • LEGAL LIABILITY IN PLASTIC SURGERY AND THE CONTRACT OF WORK • EMERGENCY MEDICAL INTERVENTION AND MEDICAL LAW PROBLEMS o Medical Forensic Examinations and Forensic Reports • INTENSIVE CARE AND MEDICAL LAW PROBLEMS • DIALYSIS AND MEDICAL LAW PROBLEMS • LIABILITIES OF PHYSICIANS • THE DETERMINATIONS ON MEDICAL LAW IN THE DECISIONS OF THE INDIVIDUAL APPLICATION TO THE TURKISH CONSTITUTIONAL COURT • CRIME OF GENITAL EXAMINATION • MISDEMEANORS IN THE FIELD OF MEDICAL LAW • THE PRACTICE OF CHEMICAL CASTRATION IN RELATION TO THE RECENT LEGAL DEVELOPMENTS • THE CONCEPT OF PATIENT’S RELATIVE IN MEDICAL LAW • THE PRACTICE OF MEDICAL LAW FROM THE PERSPECTIVE OF SOCIAL GENDER INEQUALITY • PROBLEMS IN PRACTICE ARISING FROM THE HEARINGS OF MEDICAL LAW DISPUTES IN CONSUMER COURTS • ALTERNATIVES TO MALPRACTICE LITIGATION o Mediation o Alternative Models in Comparative Law • LEGAL ASSESSMENT OF DEFENSIVE MEDICAL PRACTICES • END-OF-LIFE DECISIONS • SMART CONTRACTS IN HEALTH TOURISM • LEGAL PROBLEMS WITH FAMILY PHYSICIANS o Liability of Family Physicians Due to the Medical Reports o Liability for The Negligence of Family Physicians in Practice • MEDICAL LIABILITY INSURANCE IN MEDICAL DISPUTES *Please note that congress topics are not limited to the listed ones. We welcome all and any topics related to medical law, in particular, current issues and developments in foreign countries, which bring new insights to the issues concerning medical law.
Eintrags-ID:
1222807
5
FDA SOPs Training — FDA Compliant SOPs for Regulated Industry: How to Create High Quality SOPs that Your Team and FDA Auditors Will Love
10. Okt 2019 - 11. Okt 2019 • Boston, Vereinigte Staaten
Zusammenfassung:
SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. They are frequently poorly written, communicated, monitored and enforced. This workshop will provide step by step instructions to create SOPs for FDA-regulated organizations.
Kontakt:
Tel.: [+410 501 5777];     Email: pkumar@fdamap.com
Eintrags-ID:
1256536
6
GMP Phase I — FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials
24. Okt 2019 - 25. Okt 2019 • Boston, Vereinigte Staaten
Zusammenfassung:
Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.
Kontakt:
Tel.: [+410 501 5777];     Email: pkumar@fdamap.com
Eintrags-ID:
1256546
7
PV — 20th Pharmacovigilance 2019
07. Nov 2019 • Mumbia, Indien
Zusammenfassung:
20th Pharmacovigilance 2019 Conference provides the strongest context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies that cannot be found in any other meeting. The content of this event is developed by top experts from the biopharmaceutical industry and global regulatory agencies, and Virtue Insight will convene the best speakers from around the world to discuss the current challenges and issues that matter most to professionals working in the field.
Kontakt:
Tel.: [+91 44 24762472];     Email: kavitha@virtueinsight.co.in
Themen:
Pharmacovigilance, DrugSafety, ProductSafety, DrugDevelopment, ClinicalSafety, patientsafety, RiskManagement, regulatoryaffairs
Eintrags-ID:
1268623
8
Technical Writing — Technical and Regulatory Writing for FDA-Regulated Industry
14. Nov 2019 - 15. Nov 2019 • Boston, Vereinigte Staaten
Zusammenfassung:
Regulatory professionals have to write highly technical documents for a variety of audience. These documents include reports, protocols, clinical trial and marketing approval applications, technical reports on studies, and communication documents. This workshop will address best practices, and regulatory strategies on how to write effective documents covering anywhere from simple issues such as minutes of meetings and correspondence notes, to highly sophisticated nonclinical and clinical study reports, and regulatory submissions to FDA, EMA, Health Canada, and other regulators.
Kontakt:
Tel.: [+410 501 5777];     Email: pkumar@fdamap.com
Eintrags-ID:
1256556
9
PSW20 — 3rd Annual Pharma Security World 2020 “Supply-Chain, Drug Serialization and Anti-Counterfeiting” Conference and Expo
25. Mär 2020 - 26. Mär 2020 • London, Großbritannien
Zusammenfassung:
The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores.Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security.We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.
Kontakt:
Tel.: [02070960786];     Email: info@corvusglobalevents.com
Themen:
PharmaSecurityWorld, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecuritySerialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs
Eintrags-ID:
1247521
10
TM 2020 — 2020 International Conference and Exhibition on Traditional & Alternative Medicine
26. Mär 2020 - 27. Mär 2020 • Madrid, Spanien
Veranstalter:
Research Lake International
Zusammenfassung:
2020 International Conference and Exhibition on Traditional & Alternative Medicine during March 26-27 2020, Madrid, Spain. Traditional Medicine 2020 aims to gather leading traditional physicians’ educational scientists, researchers and research students to exchange & share their experiences and research results about all aspects of Traditional and Alternative medicine. Traditional Medicine 2020 includes prompt keynote presentations, oral talks, poster presentations and exhibitions, workshop, Symposium. We gladly welcome attendees from all around the world to present their ideas, expand their networks, knowledge, and recent innovations and inventions in the field of Traditional & Alternative Medicine.
Kontakt:
Tel.: [+1 (647) 551-8989];     Email: kate.john.0295@gmail.com
Themen:
Medicine Conference Topics: Traditional, Alternative, Herbal, Ayurveda, Chinese, Japanese, Arabic, Unani, Homeopathic, Pharmacognosy and medicine for cancer.
Eintrags-ID:
1271804


Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Stand vom 13. September 2019